D. E. Shaw & Co., Inc. Insmed Inc Transaction History
D. E. Shaw & Co., Inc.
- $100 Billion
- Q1 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Insmed Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 734,880 shares of INSM stock, worth $53.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
734,880
Previous 10,000
7248.8%
Holding current value
$53.5 Million
Previous $690,000
8025.07%
% of portfolio
0.06%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding INSM
# of Institutions
489Shares Held
197MCall Options Held
892KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.33 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.12 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$940 Million0.12% of portfolio
-
Capital International Investors Los Angeles, CA7.2MShares$524 Million0.11% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.85B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...